Geo, "taking out someone's garbage", LOL!? I see the valuation approach Unemon shared is interesting because it brings home the calculation by which future potential can be translated back to current valuation. We can all choose our own assumptions to work the concept.
I don't know whether PPHM has an Advanced Approval in its future. Comparing with a company that also hasn't achieved an AA but granting them the benefit of the doubt for value as if they will get it but not so for PPHM is just an example of different assumptions for working the valuation projections. It is up to PPHM to show an interested Pharma what should be the right input assumptions. We can only guess.
My assumption with PPHM is that measures have been implemented by external parties to keep the pps depressed until a deal is announced. We can definitely observe that something significant is positioning for change in PPHM's market cap because half the outstanding shares recently traded in three consecutive trading days, raising the pps about a buck in the process. Directionally, that indicates whoever was involved with that large volume share exchange was willing to pay a premium, which is bullish for PPHM prospects.
I still have my shares through this "Retail investor gauntlet" and have picked up more shares since the Reverse Split so that I have a bit better than the same proportion of outstanding shares in my portfolio now as I did then. Notably, PPHM valuation is now hovering around the threshold where more cost averaging purchases of shares will increase my average $ per share cost basis rather than reduce it. Considering how this timing (around now) is the first time since I initiated a position in TCLN/PPHM about a dozen years ago that buying more shares will increase my average cost basis, it is reasonable for me, at least, to project that PPHM is near an inflection point for delivery on their business plan and related release of share holder value. If the pps reverts down some more, I might find it will again improve my cost basis to buy more shares, but I already have accumulated my investment objective quantity of PPHM shares. What to do, what to do.... LOL!
Considering how there seems to be bear raids or similar measures taken to suppress the pps whenever posters on this board seem to be getting the most excited about PPHM prospects, I suppose the underlying theme is to continue to patiently wait for PPHM to deliver. It seems like good results should be a 2014 delivery, but it may take longer, since we can presume that a go it alone outcome for PPHM's Phase 3 NSCLC Bavi trial should start showing interim results later in 2014 or early 2015. Other PPHM developments could move the pps at any time.
In fact, something recently did move the pps up. Enough that call options are set to deliver a little gain relative to those purchased a month or two back, which is another rare status for PPHM trading. I picked up a few call options, for curiosity sake mostly, and plan on holding them until they are ripe. It is telling that the spread between bid and ask for $2 call options widened to $0.25 when normal might run around a dime spread. Writers of options appear to be attempting to trim back their payout in advance of... .???
Best wishes and IMO.
KT
News 
Market Data 
Discover 
AI
